LIRIO MILLER: Open Payments
NPI 1629767876 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,928 in 98 payments from 25 companies in 2025. Trend: 2023 $468 · 2024 $2,194 · 2025 $2,928
Food & beverage: $2,928
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $424 |
| Amgen Inc. | 10 | $364 |
| GlaxoSmithKline, LLC. | 12 | $281 |
| Novo Nordisk Inc | 8 | $213 |
| ABBVIE INC. | 7 | $201 |
| PFIZER INC. | 10 | $182 |
| Penumbra, Inc. | 1 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $168 |
| Aimmune Therapeutics, Inc. | 9 | $138 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
Products named: BREZTRI, Ozempic, Indigo System, CAPLYTA, EVENITY, REPATHA, ZENPEP, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
